Compare Amphastar Pharmaceuticals Inc (AMPH) vs Johnson & Johnson (JNJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs Johnson & Johnson — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $868.62M), while Johnson & Johnson trades at $258.7 (market cap $626.09B). The key difference: Johnson & Johnson is far larger — about 720.8× Amphastar Pharmaceuticals Inc's market cap, and Johnson & Johnson pays a 2.06% dividend while Amphastar Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMPH | JNJ | |
|---|---|---|
Market Cap | $868.62M | $626.09B |
Sector | Health | Health |
52-Week High | $30.81 | $267.24 |
52-Week Low | $16.87 | $172.78 |
Enterprise Value | $1.27B | $654.37B |
Volume | — | 6,156,228 |
Dividend Yield | — | 2.06% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →
